Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Taro Pharmaceutical Industries stock
Learn how to easily invest in Taro Pharmaceutical Industries stock.
Taro Pharmaceutical Industries Ltd is a drug manufacturers-specialty & generic business based in the US. Taro Pharmaceutical Industries shares (TARO) are listed on the NYSE and all prices are listed in US Dollars. Taro Pharmaceutical Industries employs 1,455 staff and has a trailing 12-month revenue of around $570.9 million.
How to buy shares in Taro Pharmaceutical Industries
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – TARO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- TARO shares summary
- Compare share dealing platforms
- Is TARO stock a buy or sell?
- Stock performance over time
- Are TARO shares over-valued?
- Taro Pharmaceutical Industries's financials
- How volatile are TARO shares?
- Does Taro Pharmaceutical Industries pay a dividend?
- Have TARO shares ever split?
- Other common questions
Taro Pharmaceutical Industries stock price (NYSE: TARO)Use our graph to track the performance of TARO stocks over time.
Taro Pharmaceutical Industries shares at a glance
|Latest market close||$29.98|
|52-week range||$28.56 - $65.21|
|50-day moving average||$34.22|
|200-day moving average||$40.68|
|Wall St. target price||$54.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$2.39|
Buy Taro Pharmaceutical Industries shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Taro Pharmaceutical Industries stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Taro Pharmaceutical Industries price performance over time
|1 week (2022-09-23)||-3.07%|
|1 month (2022-09-02)||-7.75%|
|3 months (2022-07-01)||-18.38%|
|6 months (2022-04-01)||-31.22%|
|1 year (2021-10-01)||-53.27%|
|2 years (2020-10-02)||-44.89%|
|3 years (2019-10-02)||74.48|
|5 years (2017-10-02)||114.14|
Is Taro Pharmaceutical Industries stock undervalued or overvalued?
Valuing Taro Pharmaceutical Industries stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Taro Pharmaceutical Industries's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Taro Pharmaceutical Industries's P/E ratio
Taro Pharmaceutical Industries's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 13x. In other words, Taro Pharmaceutical Industries shares trade at around 13x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Taro Pharmaceutical Industries's EBITDA
Taro Pharmaceutical Industries's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $124.7 million.
The EBITDA is a measure of a Taro Pharmaceutical Industries's overall financial performance and is widely used to measure a its profitability.
Taro Pharmaceutical Industries financials
|Revenue TTM||$570.9 million|
|Operating margin TTM||17.19%|
|Gross profit TTM||$293.1 million|
|Return on assets TTM||2.71%|
|Return on equity TTM||5.4%|
|Market capitalisation||$1.2 billion|
TTM: trailing 12 months
Taro Pharmaceutical Industries share dividends
We're not expecting Taro Pharmaceutical Industries to pay a dividend over the next 12 months.
Have Taro Pharmaceutical Industries's shares ever split?
Taro Pharmaceutical Industries's shares were split on a 2:1 basis on 27 July 2001. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Taro Pharmaceutical Industries shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Taro Pharmaceutical Industries shares which in turn could have impacted Taro Pharmaceutical Industries's share price.
Taro Pharmaceutical Industries share price volatility
Over the last 12 months, Taro Pharmaceutical Industries's shares have ranged in value from as little as $28.56 up to $65.21. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Taro Pharmaceutical Industries's is 0.7343. This would suggest that Taro Pharmaceutical Industries's shares are less volatile than average (for this exchange).
Taro Pharmaceutical Industries overview
Taro Pharmaceutical Industries Ltd. , a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1950 and is based in Haifa, Israel.
Frequently asked questionsWhat percentage of Taro Pharmaceutical Industries is owned by insiders or institutions?
Currently 78.484% of Taro Pharmaceutical Industries shares are held by insiders and 12.375% by institutions. How many people work for Taro Pharmaceutical Industries?
Latest data suggests 1,455 work at Taro Pharmaceutical Industries. When does the fiscal year end for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries's fiscal year ends in March. Where is Taro Pharmaceutical Industries based?
Taro Pharmaceutical Industries's address is: 14 Hakitor Street, Haifa, Israel, 2624761 What is Taro Pharmaceutical Industries's ISIN number?
Taro Pharmaceutical Industries's international securities identification number is: IL0010827181 What is Taro Pharmaceutical Industries's CUSIP number?
Taro Pharmaceutical Industries's Committee on Uniform Securities Identification Procedures number is: M8737E108
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert